Journal Article

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

  • Stecklein S
  • Barlow W
  • Pusztai L
  • et al.
JCO Precision Oncology (2023) (7)
DOI: 10.1200/po.23.00197
6Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Dual classification of #TNBC by HRD and DDIR is prognostic and may identify specific therapeutic vulnerabilities.

Cite

CITATION STYLE

APA

Stecklein, S. R., Barlow, W., Pusztai, L., Timms, K., Kennedy, R., Logan, G. E., … Sharma, P. (2023). Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency. JCO Precision Oncology, (7). https://doi.org/10.1200/po.23.00197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free